Colon tumours are hierarchically organized and contain multipotent self-renewing cells,
Lgr5, a reported CSCs marker. The existence of distinct stem cell populations within intestinal tumours highlights the necessity of better understanding their hierarchy and behaviour, to identify the correct cellular targets for therapy.
Introduction
Intestinal crypts have been reported to harbour two distinct types of stem cells: homeostatic stem cells, marked by the G-protein coupled receptor Lgr5 1 , that continuously generate new progenitors to ensure efficient renewal of the intestinal mucosa, and presumably quiescent stem cells, thought to provide a reserve source of stem cells that can be activated upon injury 2, 3 . We have shown that the Notch1 receptor is expressed in both homeostatic and reserve stem cells populations in vivo, providing a valuable tool to mark both cell types and dissect their hierarchical relationship 4 . Intestinal tumours have been proposed to originate from intestinal stem cells (ISCs) or very early progenitors, as these are the only cells that persist long enough within the tissue to ensure clonal expansion of a mutant progeny 5 . However, it should be noted that differentiated cells and/or intestinal progenitors have been shown to be able to undergo dedifferentiation upon activation of specific pathways and to acquire stem cell properties that may result in tumour formation 6 .
However, these studies are based on genetic targeting of specific oncogenic mutations, while direct evidence showing the presence of CSCs within spontaneously arising intestinal tumours is still poor. Recently, a lineage tracing study in intestinal and colonic tumours using two stem cell-specific promoters, Lgr5 and Bmi1 7 , proposed that these two ISCs markers can be used to detect different stem cell populations in intestinal tumours 8 . We have previously shown that the specific expression of the Notch1 receptor in ISCs promotes active Notch signalling in these cells 4 and, consistently with its essential role in intestinal homeostasis and cell fate determination 9 , Notch activity has been reported as essential for crypt stem cells maintenance 10 . Of relevance, Notch signalling is required for intestinal tumour formation and it cooperates with the Wnt pathway to promote crypt hyperplasia 11, 12 . On these premises, we assessed whether the expression of the Notch1 receptor labels CSCs in intestinal and colon adenomas derived from both a genetic mouse model and a carcinogenic protocol. We performed clonal analysis using the Notch1-Cre ERT2 mouse line, which we have previously shown to mark multipotent ISCs in the small intestine and colon 4 , and assessed the identity and fate of Notch1+ cells within spontaneously arising intestinal tumours.
We show that Notch1-labeled cells represent a distinct population of CSCs within both intestinal and colon tumours, which contributes to tumour growth by clonal expansion and generates intra-tumoural heterogeneity. These in vivo studies provide evidence for the existence of different types of CSCs in intestinal tumours, which might have different origins and/or exhibit differential response to treatment.
Results

Notch1Cre ERT2 labels undifferentiated and proliferative tumour cells
To track Notch1+ intestinal adenoma cells in vivo, we generated a triple transgenic mouse (hereafter referred to as N1-Cre/mTmG/Apc) by crossing mice carrying both the Notch1-Cre ERT2 (N1-Cre) 4 and the Rosa26 mTmG (mTmG) 13 reporter with Apc +/1638N (Apc) mutant mice 14 (Fig. 1a) . Apc mice harbour a heterozygous germline mutation in the Apc tumour suppressor gene and spontaneously develop intestinal adenomas, initially detectable at around six months of age, due to loss of heterozygosity (LOH) at the Apc locus. In our compound N1-Cre/mTmG/Apc mice, the membrane-associated red fluorescent protein (mT) is expressed in all cells, while membrane-associated GFP (mG) marks Cre-targeted cells. To identify the cells expressing the Notch1 receptor within tumours, N1-Cre/mTmG/Apc tumourbearing mice received a single dose of tamoxifen and were analysed 24h later ( Fig. 1b ).
Quantification by flow cytometry of the proportion of Notch1+ cells within tumour epithelial cells (referred as TEC, selected with the markers EpCAM+/Lin-, gate strategies are detailed in Supplementary Fig. 1 ), indicated, in agreement with our immunofluorescence results, that Notch1-expressing epithelial cells represent a rare tumour cell population comprising 1,2% ± 0,3% of TEC ( Fig. 1c ). It should be noted that, as the N1-Cre line also labels other types of stromal cells, we exclusively focused our analysis on epithelial cells, expressing the epithelial marker EpCAM (Epithelial cell adhesion molecule 15 (Fig. 1d ). Since Apc mutant intestinal tumours present differentiated tumour cells, we evaluated if Notch1 is expressed in such cells by immunostaining for differentiation markers for secretory cells, such as Agglutinin (Ulex Europaeus Agglutinin, labelling both Paneth and Goblet cells), Lysozyme1 (a specific marker of Paneth cells) 16 and Mucin2 (expressed in Goblet cells 17 ) ( Fig. 1d ). None of these markers was expressed in GFP+ cells, consistently with the lack of Notch1 expression in secretory cells in the normal intestinal epithelium 9 . We also assessed the expression of secretory and enterocyte (Alkaline Phosphatase Intestinal, Alpi 18 ) markers by qRT-PCR on sorted tumour cells and confirmed that GFP+ cells show strongly reduced levels of expression for all of these markers ( Fig. 1e ), indicating that the N1-Cre mouse line labels undifferentiated tumour cells.
Notch1 expression defines multipotent tumour cells with self-renewal capacity
To map the fate of Notch1+ tumour cells and establish their self-renewal capacity in vivo, we examined tumour-bearing N1-Cre/mTmG/Apc mice at different time points after administration of tamoxifen, from 4 days up to 90 days ( Fig. 2a ). Our experimental approach required that we started tracing in tumour-bearing mice (thus in 6-month old animals, which generally succumb 2 to 3 months later) and consequently, a 90 days chase was the longest chase period for clonal analysis. Lineage tracing showed that Notch1+ tumour cells rapidly generate clones of marked progeny, visible already 4 days after labelling, and that these clones enlarge over time ( Fig. 2b) . To quantify the clonal expansion of Notch1 lineages in vivo in growing tumours, we used two different methods: by FACS analysis, we assessed the percentage of GFP+ cells within total TEC at each time point ( Supplementary Fig. 2a and 2b); by immunofluorescence, we quantified the GFP+ tumour area within the total tumour surface, defined by the expression of the Tomato fluorescent protein ( Supplementary Fig.   2c ). From 24h post-tamoxifen up to 90 days, the proportion of GFP+ tumour cells quantified by FACS increased from 1,2% ± 0,3% to 6,1% ± 1,95% within total TEC ( Fig. 2c) . A twoparameter logarithmic function yielded the best fit to describe both quantification methods.
This function predicts that Notch1+ lineages will persist in adenomas and continue to slowly expand even after 90 days, indicating self-renewal capacity (Fig. 2c ). In addition, Notch1+ tumour cells appear more proliferative than non-marked tumour cells ( Fig. 2d ). We next assessed the cellular composition of Notch-derived clones and found that Notch1+ tumour cells can generate the repertoire of different cell types found within intestinal adenomas, as Notch1 lineages contain both proliferative (marked by Proliferating Cell Nuclear Antigen, PCNA in Fig. 2e ) and differentiated tumour cells (marked by Lyz1, Muc2 and ChgA in Fig.   2e ). The longevity of Notch1-expressing tumour cells, along with their multipotency, establishes that Notch1 is expressed in vivo in CSC.
The transcriptional signature of Notch1+ tumour cells reveals a close correlation with the gene expression profile of normal ISCs
To molecularly characterize the tumour cells that express the Notch1+ receptor, we initially assessed the expression of selected genes in sorted cells by qRT-PCR. We confirmed that GFP+ cells expressed high levels of GFP, Notch1, Nrarp, Hes1 and Olfm4, the three-latter representing direct Notch targets [19] [20] [21] , (Fig. 3a) , indicating that the Notch pathway is indeed active in Notch1+ tumour cells. Notch1+ tumour cells (GFP+) also showed enriched expression in reported markers of ISCs, such as Ascl2 22 , Hopx 2 , Musashi1 (Msi1) 23 and Bmi1 7 compared to GFP-cells within the same tumours ( Fig. 3a ). Next, we defined the (Fig. 3b ).
Unexpectedly, while in normal crypts the Notch1 and Lgr5 transcripts are enriched within the same cells, Notch1+ tumour cells showed a reduction in Lgr5 expression compared to nonlabeled cells ( Fig. 3b -c).
The expression profile of Notch1+ tumour cells highly correlates, by Gene Set
Enrichment Analysis (GSEA), with published transcriptomic signatures defining normal ISCs 31 (Fig. 3d ) and their proliferative features 33 (Fig. 3e ). Consistently, we also found a tight correlation between the cells that express Notch1 in normal crypts and in tumours ( Fig. 3f ).
These results suggest that the transcriptional signature is not substantially changed between normal ISCs and CSCs, although we could detect a significant activation of proliferative and oncogenic pathways, such as MAPK, EGFR, FGF, VEGF and Wnt, in Notch1+ tumour cells compared to Notch1+ normal ISCs ( Fig. 3g and full pathway analysis list in Supplementary   Table 1 ). Collectively, these results indicate that Notch1-expressing tumour cells are transcriptionally related to normal ISCs. Based on the comparison between these two transcriptional signatures, it is tempting to speculate that Notch1+ CSCs originate from ISCs.
Notch1 and Lgr5 lineages are hierarchically organized
Given our surprising results in terms of Lgr5 expression in Notch1+ cells, we then compared the signature of Notch1+ tumour cells to the transcriptome of Lgr5+ tumour cells 34 , and found an inverse correlation by GSEA, suggesting major differences between these two tumour cell populations ( Fig. 3h ). To explore the hierarchy between these two tumour cell populations, we used the mTmG double fluorescent line, allowing us to distinguish between initially labelled cells (that we called "mother cells") and their derived progeny. Notch1expressing cells are isolated 24h after tamoxifen administration; within such a short chase, Notch1+ cells have turned green (GFP+) but retain the expression of the Tomato protein, due to protein stability, so they are GFP+ and Tom+. By labelling Notch lineages in tumours during a 60 days chase and giving a second tamoxifen pulse 24h prior to tumour dissection ( Fig. 4a ), we can distinguish the recently labelled cells ("mother cells", expressing both GFP and Tomato) from their progeny (GFP+ but Tomato-) and from non-labelled cells (GFP-and Tomato-) ( Fig. 4b ). The analysis by qRT-PCR of these three FACS sorted populations showed that Notch1-derived lineages express intermediate levels of both Lgr5 and differentiation markers, such as lysozyme, between non-labelled cells (in red) and Notch1expressing tumour cells (in green) ( Fig. 4c ). These results are consistent with our clonal analysis, suggesting that multipotent Notch1+ tumour cells can give rise to heterogeneous lineages comprising distinct cell types, such as differentiated cells (Lyz1+), and raises the intriguing possibility that Notch1+ tumour cells might generate Lgr5+ tumour cells, thus contributing to tumour growth and propagation.
Clonal analysis of Notch1+ tumour cells in chemically induced colon tumours
Our clonal analysis in genetically modified mouse models indicated that the Notch1 receptor is expressed in a population of CSCs in intestinal adenomas. To further validate the clinical value of our study, we then examined if Notch1 expression could assist in identifying CSCs in chemically induced colon tumours, the most predominant location in colorectal cancer (CRC) patients. For these studies, we administered azoxymethane (AOM), followed by 2 cycles of exposure to the inflammatory agent dextran sodium sulphate (DSS) 35 to N1-Cre/mTmG mice. Upon colon tumour formation, which we monitored by colonoscopy 36 , we induced GFP expression with a single dose of tamoxifen and analysed the tumours at different chase times (24h, 48h, 15 days and 2 months) ( Fig. 5a ). The presence of uniformly scattered GFP+ cells 24 hours post-tamoxifen in all colon tumours analysed demonstrated that Notch1 is also expressed in chemically-induced colon tumours ( Fig. 5b ). Consistently with our results in Apc mutant adenomas, Notch1+ colon tumour cells were also undifferentiated and proliferative, as they rapidly produced a clonal progeny, evident at 15 days after induction. A 2-month chase showed that Notch1-derived clones had considerably grown, suggesting that Notch1+ colon tumour cells self-renew, like their small intestinal counterparts ( Fig. 5b ).
To assess multipotency of the Notch1+ colon cancer cells, we analysed their clonal progeny (EpCAM+) and found that they expressed both proliferation (Ki67+) and differentiation markers (i.e. Mucin2 shown in Fig. 5c ), demonstrating that Notch1-expressing cells in colon tumours have multilineage differentiation potential and present the same properties of Notch1+ intestinal adenoma cells. Notch1-expressing cells represent thus genuine CSCs in both genetic and carcinogenic tumour models. It remains uncertain however to what extent these cells contribute to the overall tumour development and growth.
Discussion
Our study shows that Notch1+ expression labels a previously uncharacterized and distinct population of undifferentiated and self-renewing tumour cells, which clonally expand during tumour growth and generate heterogeneous lineages. Importantly, our findings suggest that Notch1+ tumour cells do not coincide with CSCs expressing the Lgr5 receptor, while they rather share a transcriptional signature with normal ISCs. In the normal intestine, two types of ISCs have been defined: rapidly dividing crypt-based columnar (CBCs) cells at the bottom of the crypt and "+4" ISCs (often called reserve stem cells), located at position +4 above the crypt base and considered as slower cycling cells 1, 7 . We have previously shown that Notch1 expression marks both types of ISCs 4 . The fact that Notch1+ tumour cells present an expression profile very similar to the signature of Notch1+ ISCs (Fig. 3f ), prompts us to speculate that Notch1+ tumour cells might derive from +4 ISCs, shown to express lower levels of Lgr5 than CBCs, and paramount for intestinal regeneration 3 .
It is noteworthy that our data show an inverse correlation between the transcriptional profile of Notch1+ tumour cells and the signature of Lgr5+ tumour cells published by Schepers and colleagues 34 . Such discrepancy might be due to the different models used in the two studies: Schepers et al. analysed Lgr5-expressing cells within intestinal tumours in which the homozygous deletion of the Apc gene had been specifically targeted to Lgr5+ cells 34 . This approach greatly differs from our study, where we traced Notch1+ cells in spontaneously arising tumours that lost the wt Apc allele by loss of heterozygosis (LOH). In this model, we found that Notch1+ tumour cells strikingly resemble their normal counterparts, inferring that they might represent normal stem cells that were engulfed during tumour growth and thrive in the tumour environment thanks to paracrine mitogenic signals from surrounding cells ( Fig. 6 ). Our work suggests the possibility that normal ISCs might contribute to tumour expansion and heterogeneity. We also show that, independently of their 37, 38 , it remains to be established whether deletion of Notch1+ CSCs would be beneficial to block or retard tumour progression.
Further functional studies will reveal the differences between the distinct CSCs populations revealed in this study, in particular regarding their respective clonogenic and tumourigenic potential. It will also be crucial to test their resistance to commonly used chemotherapeutic drugs, to possibly stratify patients based on their relative abundance.
Methods
Mice
The N1-CreERT2 SAT 4 and Apc +/1638 14 mouse lines have been crossed to the dual fluorescent reporter Rosa26mT/mG strain 13 . GFP reporter expression was induced in N1- 
Fitting curve
The concatenated fit of the GFP cells expansion data from FACS and the surface-based methods was obtained using OriginLab software (OriginLab Inc., MA, USA). To account for the initial rapid increase and later slower growth of the GFP population, a logarithmic function has been chosen, and the quality of the fitting was judged by visual inspection and analysis of fit residuals and proved more appropriate than using an exponential decay function.
Cell cycle analysis by FACS
After dissociation, cells were fixed in 2% PFA for 20 minutes at 4°C. Cells were washed twice in 1X PBS upon centrifugation at 400g, 4 minutes at 4°C, and staining proceeded. Cells were then incubated in pre-warmed 1X PBS Hoechst 33342 (1:100, stock at 10mg/ml) solution for 20 minutes at 37°C. FlowJo software was used for data analysis.
Microscopy and image acquisition
For image acquisition, we used an upright confocal spinning disk (Roper/Zeiss), equipped with a CoolSnap HQ2 camera and 405nm, 491, 561 and 642nm lasers. Images were captured using Metamorph. Image processing was performed using ImageJ software. 
Flow cytometry
RNA extraction and qRT-PCR
RNA extraction was performed using Qiagen kit according to the manufacturer's instructions.
Reverse transcription was performed using the SuperScript III First-Strand Synthesis System Table 2 ) was evaluated relatively to the slope obtained by the quantification of a standard curve, and the presence of a single amplicon at the expected size was checked on an 2% agarose gel. Results were normalized to the expression of 18S, GAPDH and β-actin housekeeping genes and the relative expression was obtained with the -ΔΔCt method.
AOM/DSS colon carcinogenesis experimental protocol
To induce colon carcinogenesis, we adjusted the protocol from Tanaka and colleagues 35 and a set of N1/mTmG mice ranging from 5 to 7 months of age were administered a single intraperitoneal injection of Azoxymethane (AOM, Sigma #A5486) followed by Dextran Sulfate Sodium (DSS, MP Biomedicals #160110) treatment (3% in drinking water) the day after the AOM injection for 5 consecutive days. General health status and mouse body weight were monitored daily during and after treatment. To verify the presence of colon tumours, 2 mice were checked 1 month after the first cycle of DSS treatment, but no tumours were detected (only signs of inflammation). We administered another cycle of DSS (3% in drinking water) for 3 days and tumour formation was monitored by colonoscopy using a Karl-Storz endoscopic system (as previously described 36 ).
Affymetrix analyses and sample quality control
Transcriptome profiles were obtained using Affymetrix Mouse Gene ST 2.1 arrays. For each condition, three biological replicates were performed, by pooling intestinal adenomas and crypt fractions from more than 3 mice per replicate. cDNAs were synthesized from total RNA and hybridized by the Institut Curie Genomics Platform. Data normalization and analysis were performed using the R software (version 3.3.2). Raw data have been first normalized using the RMA method (R package affy 1.5.2, 39 ), and annotated using the BrainArray Mus musculus mogene21st annotation library (19.0.2). Non-annotated or lowly expressed genes (<3.5) were discarded from the analysis. Differential analysis were performed using the Limma package (3.24.3) 40 and the following linear model: Y ij = mu i + T t + G g + (T*G) tg + E ijtg where Y ij is the expression of gene i in sample j, T is the effect of sample type 41 and G is the effect of GFP status. Results of the differential analysis have been corrected from multiple testing using the Benjamini-Hochberg procedure.
Differentially expressed genes in the comparison of Normal GFP+ (Notch1+ ISCs) vs
Tumour GFP+ (Notch1+ tumour cells), and Tumour GFP+ vs Tumour GFP-(non-labelled tumour cells), have been defined using an adjusted p-value of 5% and a minimum log fold change of 1.
We then performed GSEA analysis (with -nperm 1000 -permute gene_set -collapse false parameters) using the same expression matrix (v2.2.2) comparing the Tumour GFP+ and GFP-samples 41 . Transcriptional signatures used for the analysis were extracted from the literatures 31, 33, 34 . Normal GFP+ vs -signature have been defined using an adjusted p-value threshold to 25% and a minimum log fold change of 0.5. Tajbakhsh for kindly providing the Apc1638 mice and the mTmG reporter line, respectively.
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The authors declare no competing interests. in an ISC to initiate crypt hyperplasia (crypt foci, in red). In such a scenario, Notch1+ normal ISCs become surrounded by mutant tumour-initiating cells (red cells), and thus get engulfed in the tumour. As mutant cells expand, their tumour microenvironment provides signals that potentiate the growth of these "embedded ISCs" (eISCs, in green), which express lower levels of Lgr5 relatively to normal ISCs and to the tumour bulk (see Fig. 3c ). As the adenoma continues to develop over time, eISCs remain proliferative and multipotent within tumour glands, actively producing differentiated cells and generating new Notch1+ CSCs, but also Lgr5+ CSCs (red cells) that display lower levels of Notch1, as we speculate (see Fig. 4c ). The existence of two types of CSCs, one predominantly expressing Notch1 and the other Lgr5, might contribute to intra-tumoural heterogeneity, which drives tumour progression, by escaping to targeted therapies. Whether Lgr5+ CSCs are reciprocally able to produce/interconvert into Notch1+ CSCs remains to be established.
Figure Legends
Supplementary Figure 1. Gate strategies for FACS analysis
Representative dot plots of the FACS gating strategies used in this study. Live cells were gated 
